Alpha-mannosidosis

Orphanet Journal of Rare Diseases

Volumn 3, Issue 1, 2008, Pages

  Malm, Dag ^a   Nilssen, Øivind ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MANNOSIDASE;

CHEMICAL STRUCTURE; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; GENETIC COUNSELING; GENETICS; HUMAN; MANNOSIDOSIS; MUTATION; PATHOLOGY; PROGNOSIS; PROTEIN CONFORMATION; REVIEW;

ALPHA-MANNOSIDASE; ALPHA-MANNOSIDOSIS; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; HUMANS; MODELS, MOLECULAR; MUTATION; PROGNOSIS; PROTEIN CONFORMATION;

EID: 49649104562     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-3-21     Document Type: Review

References (72)

1. A generalised storage disorder resembling Hurler's syndrome. PA Ockerman, Lancet 1967 2 239 10.1016/S0140-6736(67)92303-3
2. Mannosidosis: isolation of oligosaccharide storage material from brain. PA Ockerman, J Pediatr 1969 75 360 365 10.1016/S0022-3476(69)80259-3 4979626
3. Mannosidosis. H Loeb E Vamos-Hurwitz, Arch Neurol 1977 34 650 651 907542
4. A new variant of mannosidosis with increased residual enzymatic activity and mild clinical manifestation. G Bach G Kohn EE Lasch M El Massri A Ornoy E Sekeles C Legum MM Cohen, Pediatr Res 1978 12 1010 1015 10.1203/00006450- 197810000-00012 724292
5. The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation. P Heikinheimo R Helland HK Leiros I Leiros S Karlsen G Evjen R Ravelli G Schoehn R Ruigrok OK Tollersrud S McSweeney E Hough, J Mol Biol 2003 327 631 644 10.1016/S0022-2836(03)00172-4 12634058
6. Zinc therapy in the bovine mannosidosis model. RD Jolly NS Van de Water A Janmaat PM Slack RG McKenzie, Birth Defects Orig Artic Ser 1980 16 305 318 7448359
7. Oral zinc therapy in the treatment of alpha-mannosidosis. LT Wong H Vallance A Savage AG Davidson D Applegarth, Am J Med Genet 1993 46 410 414 10.1002/ajmg.1320460413 8357013
8. Towards the Development of an Effective Enzyme Replacement Therapy for Human á-Mannosidosis. HUE-MAN, 2006 http://www.uni-kiel.de/Biochemie/hue- man/
9. Mannosidosis: clinical, morphologic, immunologic, and biochemical studies. RJ Desnick HL Sharp GA Grabowski RD Brunning PG Quie JH Sung RJ Gorlin JU Ikonne, Pediatr Res 1976 10 985 996 10.1203/00006450-197612000-00008 995502
10. The clinical course of mannosidosis. S Autio T Louhimo M Helenius, Ann Clin Res 1982 14 93 97 7149616
11. Alpha-mannosidosis and mutational analysis in a Turkish patient. A Olmez O Nilssen T Coskun H Klenow, Turk J Pediatr 2003 45 46 50 12718372
12. Adult alpha-mannosidosis: clinical progression in the absence of demyelination. A Gutschalk I Harting M Cantz C Springer K Rohrschneider HM Meinck, Neurology 2004 63 1744 1746 15534274
13. Sisters with alpha-mannosidosis and systemic lupus erythematosus. M Urushihara S Kagami K Yasutomo M Ito S Kondo A Kitamura D Malm H Klenow O Nilssen Y Kuroda, Eur J Pediatr 2004 163 192 195 10.1007/s00431-004-1404-2 14760529
14. Mannosidosis. MA Chester A Lundblad PA Öckerman S Autio, Genetic Errors of Glyco-Protein Metabolism Milan: Edi-Hermes, Duran P, O'Brien JF, 1982 89 120
15. Spectrum of mutations in alpha-mannosidosis. T Berg HM Riise GM Hansen D Malm L Tranebjaerg OK Tollersrud O Nilssen, Am J Hum Genet 1999 64 77 88 9915946 10.1086/302183
16. Alpha-Mannosidosis. GeneReviews. D Malm O Nilssen, Medical Genetics Information Resource [Database online] 2006 http://www.geneclinics.org/
17. [Alpha-mannosidosis]. D Malm OK Tollersrud L Tranebjaerg JE Mansson, Tidsskr Nor Laegeforen 1995 115 594 597 7900112
18. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy. PJ Meikle E Ranieri H Simonsen T Rozaklis SL Ramsay PD Whitfield M Fuller E Christensen F Skovby JJ Hopwood, Pediatrics 2004 114 909 916 10.1542/peds.2004-0583 15466084
19. Mannosidosis: phenotype of a severely affected child and characterization of alpha-mannosidase activity in cultured fibroblasts from the patient and his parents. AS Aylsworth HA Taylor CM Stuart GH Thomas, J Pediatr 1976 88 814 818 10.1016/S0022-3476(76)81120-1 5584
20. Communicating hydrocephalus and lysosomal inclusions in mannosidosis. JJ Halperin DM Landis LA Weinstein IT Lott EH Kolodny, Arch Neurol 1984 41 777 779 6331356
21. Developmental analysis of CNS pathology in the lysosomal storage disease alpha-mannosidosis. AC Crawley SU Walkley, J Neuropathol Exp Neurol 2007 66 687 697 10.1097/nen.0b013e31812503b6 17882013
22. First reported case of alpha-mannosidosis in the RSA. G de Jong EM Petersen, S Afr Med J 1992 82 126 128 1509325
23. Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention. E Odunusi C Peters W Krivit J Ogilvie, J Pediatr Orthop 1999 19 270 274 10.1097/00004694-199903000- 00026 10088702
24. Severe destructive polyarthropathy in association with a metabolic storage disease. A case report. DG Eckhoff JS Garlock, J Bone Joint Surg Am 1992 74 1257 1261 1400557
25. Mannosidosis: an unusual cause of a deforming arthropathy. DE DeFriend AE Brown CW Hutton PM Hughes, Skeletal Radiol 2000 29 358 361 10.1007/ s002560000213 10929420
26. Destructive joint disease in alpha-mannosidosis. A case report and review of the literature. AH Gerards WP Winia J Westerga BA Dijkmans RM van Soesbergen, Clin Rheumatol 2004 23 40 42 10.1007/s10067-003-0770-x 14749981
27. Bilateral patellar dislocation associated with alpha-mannosidase deficiency. SS Hale JG Bales S Rosenzweig P Daroca JT Bennett, J Pediatr Orthop B 2006 15 215 219 16601592
28. Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. JR Ara E Mayayo ME Marzo S Guelbenzu A Chabás MA Pina C Calderón, Childs Nerv Syst 1999 15 369 371 10.1007/s003810050416 10447604
29. Hearing loss due to mannosidosis and otitis media with effusion. A case report and review of audiological assessments in children with otitis media with effusion. AU Ahmmed SM O'Halloran NJ Roland M Starkey JE Wraith, J Laryngol Otol 2003 117 307 309 12816222
30. Ocular findings in mannosidosis. AI Arbisser AL Murphree CA Garcia RR Howell, Am J Ophthalmol 1976 82 465 471 961797
31. Mannosidosis: a clinical and histopathologic study. B Kjellman I Gamstorp A Brun PA Ockerman B Palmgren, J Pediatr 1969 75 366 373 10.1016/S0022-3476(69) 80260-X 4979627
32. Clinical manifestations of mannosidosis - a longitudinal study. JJ Yunis RC Lewandowski Jr SJ Sanfilippo MY Tsai I Foni HH Bruhl, Am J Med 1976 61 841 848 10.1016/0002-9343(76)90408-3 1008071
33. Long-term follow-up of biochemical and cognitive functioning in patients with mannosidosis. RB Noll ML Netzloff R Kulkarni, Arch Neurol 1989 46 507 509 2712747
34. Unusual clinical and ultrastructural features in a boy with biochemically typical mannosidosis. BA Gordon R Carson MD Haust, Acta Paediatr Scand 1980 69 787 792 10.1111/j.1651-2227.1980.tb07154.x 7211364
35. Mannosidosis: two brothers with different degrees of disease severity. ML Mitchell RP Erickson D Schmid V Hieber AK Poznanski SP Hicks, Clin Genet 1981 20 191 202 7307317
36. Phenotypic variability of mannosidosis type II: report of two Greek siblings. H Michelakakis E Dimitriou C Mylona-Karayanni CS Bartsocas, Genet Couns 1992 3 195 199 1472354
37. MR findings in mannosidosis. JL Dietemann MM Filippi de la Palavesa C Tranchant B Kastler, Neuroradiology 1990 32 485 487 10.1007/BF02426460 2287376
38. Psychiatric symptoms in alpha-mannosidosis. D Malm J Pantel OM Linaker, J Intellect Disabil Res 2005 49 865 871 10.1111/j.1365-2788.2005.00765.x 16207285
39. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. F Sedel N Baumann JC Turpin O Lyon-Caen JM Saudubray D Cohen, J Inherit Metab Dis 2007 631 641 10.1007/s10545-007-0661-4 17694356
40. Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. D Malm DS Halvorsen L Tranebjaerg H Sjursen, Eur J Pediatr 2000 159 699 703 10.1007/s004310000545 11014473
41. Glycoprotein lysosomal storage disorders: alpha- and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency. JC Michalski A Klein, Biochim Biophys Acta 1999 1455 69 84 10571005
42. Differential binding of lectins IL-2 and CSL to candida albicans and cancer cells. JP Zanetta R Bonaly S Maschke G Strecker JC Michalski, Glycobiology 1998 8 221 225 10.1093/glycob/8.3.221 9451031
43. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. RS Green EL Stone M Tenno E Lehtonen MG Farquhar JD Marth, Immunity 2007 27 308 320 10.1016/j.immuni.2007.06.008 17681821
44. Renal transplantation in a case of mannosidosis. GP Segoloni L Colla M Messina P Stratta, Transplantation 1996 61 1654 1655 10.1097/00007890-199606150- 00019 8669114
45. Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study. DP Roces R Lüllmann-Rauch J Peng C Balducci C Andersson O Tollersrud J Fogh A Orlacchio T Beccari P Saftig K von Figura, Hum Mol Genet 2004 13 1979 1988 10.1093/hmg/ddh220 15269179
46. In vitro hydrolysis of oligomannosyl oligosaccharides by the lysosomal alpha-D-mannosidases. JC Michalski JF Haeuw JM Wieruszeski J Montreuil G Strecker, Eur J Biochem 1990 189 369 379 10.1111/j.1432-1033.1990.tb15498.x 2338081
47. Mammalian alpha-mannosidases - multiple forms but a common purpose? PF Daniel B Winchester CD Warren, Glycobiology 1994 4 551 566 10.1093/glycob/4.5. 551 7881169
48. The substrate specificity of bovine and feline lysosomal alpha-D-mannosidases in relation to alpha-mannosidosis. R DeGasperi S al Daher PF Daniel BG Winchester RW Jeanloz CD Warren, J Biol Chem 1991 266 16556 16563 1885586
49. Urinary oligosaccharides of mannosidosis. K Yamashita Y Tachibana K Mihara S Okada H Yabuuchi A Kobata, J Biol Chem 1980 255 5126 5133 7372628
50. Disorders of Glycoprotein Degradation: Alpha-Mannosidosis, beta-Mannosidosis, Fucosidosis, and Sialidosis. GH Thomas, The Metabolic & Molecular Basis of Inherited Diseases New York: McGraw-Hill, Schriver CR, Beudet AL, Sly WS, 8 2001 III 3507 3516
51. Genomic structure of the human lysosomal alpha-mannosidase gene (MANB). HM Riise T Berg O Nilssen G Romeo OK Tollersrud I Ceccherini, Genomics 1997 42 200 207 10.1006/geno.1997.4668 9192839
52. Characterization of the human MANB gene encoding lysosomal alpha-D-mannosidase. N Wakamatsu Y Gotoda S Saito H Kawai, Gene 1997 198 351 357 10.1016/S0378-1119(97)00337-5 9370301
53. Cloning, expression, purification, and characterization of the human broad specificity lysosomal acid alpha-mannosidase. YF Liao A Lal KW Moremen, J Biol Chem 1996 271 28348 28358 10.1074/jbc.271.20.11838 8910458
54. alpha-Mannosidosis: functional cloning of the lysosomal alpha-mannosidase cDNA and identification of a mutation in two affected siblings. O Nilssen T Berg HM Riise U Ramachandran G Evjen GM Hansen D Malm L Tranebjaerg OK Tollersrud, Hum Mol Genet 1997 6 717 726 10.1093/hmg/6.5.717 9158146
55. Missense and nonsense mutations in the lysosomal alpha-mannosidase gene (MANB) in severe and mild forms of alpha-mannosidosis. Y Gotoda N Wakamatsu H Kawai Y Nishida T Matsumoto, Am J Hum Genet 1998 63 1015 1024 9758606 10.1086/302048
56. Characterization of a novel alpha-mannosidosis-causing mutation and its use in leukocyte genotyping after bone marrow transplantation. HM Frostad Riise GM Hansen OK Tollersrud O Nilssen, Hum Genet 1999 104 106 107 10.1007/s004390050918 10071201
57. Two novel mutations in the gene for human alpha-mannosidase that cause alpha-mannosidosis. T Beccari L Bibi R Ricci D Antuzzi A Burgalossi E Costanzi A Orlacchio, J Inherit Metab Dis 2003 26 819 820 10.1023/B:BOLI.0000010006.87571. 48 14765545
58. Identification and characterization of five novel MAN2B1 mutations in Italian patients with alpha-mannosidosis. M Sbaragli L Bibi MG Pittis C Balducci P Heikinheimo R Ricci D Antuzzi R Parini L Spaccini B Bembi T Beccari, Hum Mutat 2005 25 320 10.1002/humu.9310 15712269
59. Funtional characterization of four novel MAN2B1 mutations causing juvenile onset alpha-mannosidosis. MG Pittis AL Montalvo P Heikinheimo M Sbaragli C Balducci E Persichetti L Van Maldergem M Filocamo B Bembi T Beccari, Clin Chim Acta 2007 375 136 139 10.1016/j.cca.2006.06.034 16919251
60. Early onset alpha-mannosidosis with slow progression in three Hispanic males. MJ Lyons T Wood L Espinoza HM Stensland KR Holden, Dev Med Child Neurol 2007 49 854 857 17979865
61. Intracellular transport of human lysosomal alpha-mannosidase and alpha-mannosidosis-related mutants. G Hansen T Berg HM Riise Stensland P Heikinheimo H Klenow G Evjen Ø Nilssen OK Tollersrud, Biochem J 2004 381 537 546 15035660 10.1042/BJ20031499
62. Alpha-mannosidosis: analysis of urinary oligosaccharides with high performance liquid chromatography and diagnosis of a case with unusually mild presentation. TG Warner AK Mock WL Nyhan JS O'Brien, Clin Genet 1984 25 248 255 6705257
63. Lymphocytes transfer only the lysosomal form of alpha-D-mannosidase during cell-to-cell contact. D Abraham H Muir B Winchester I Olsen, Exp Cell Res 1988 175 158 168 10.1016/0014-4827(88)90263-7 3345799
64. Oligomannosides or oligosaccharide-lipids as potential substrates for rat liver cytosolic alpha-D-mannosidase. T Grard V Herman A Saint-Pol D Kmiecik O Labiau AM Mir C Alonso A Verbert R Cacan JC Michalski, Biochem J 1996 316 Pt 3 787 792 8670153
65. Heterogeneity of urinary oligosaccharides from mannosidosis: mass spectrometric analysis of permethylated Man9, Man8, and Man7 derivatives. H Egge JC Michalski G Strecker, Arch Biochem Biophys 1982 213 318 326 10.1016/0003-9861(82)90468-4 7059183
66. Cell contact induces the synthesis of a lysosomal enzyme precursor in lymphocytes and its direct transfer to fibroblasts. I Olsen D Abraham I Shelton G Bou-Gharios H Muir B Winchester, Biochim Biophys Acta 1988 968 312 322 10.1016/0167-4889(88)90022-5 3278745
67. Bone marrow transplantation in the treatment of alpha-mannosidosis. A Will A Cooper C Hatton IB Sardharwalla DI Evans RF Stevens, Arch Dis Child 1987 62 1044 1049 3314721
68. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. SU Walkley MA Thrall K Dobrenis M Huang PA March DA Siegel S Wurzelmann, Proc Natl Acad Sci USA 1994 91 2970 2974 8159689 10.1073/pnas.91.8.2970
69. Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation. SS Grewal EG Shapiro W Krivit L Charnas LA Lockman KA Delaney SM Davies DA Wenger FL Rimell S Abel AC Grovas PJ Orchard JE Wagner C Peters, J Pediatr 2004 144 569 573 10.1016/j.jpeds.2004.01.025 15126988
70. Bone marrow transplantation for the treatment of alpha-mannosidosis. DA Wall DK Grange P Goulding M Daines A Luisiri S Kotagal, J Pediatr 1998 133 282 285 10.1016/S0022-3476(98)70237-9 9709723
71. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs. AC Crawley B King T Berg PJ Meikle JJ Hopwood, Mol Genet Metab 2006 89 48 57 10.1016/j.ymgme.2006.05.005 16807033
72. The PyMOL Molecular Graphics System. WL DeLano, DeLano Scientific, Palo Alto, CA, USA 2002 http://www.pymol.org